20 categories
Pharmacology
Receptor biology, pharmacokinetics and formulation chemistry — the mechanistic layer under everything else.
50 topics · page 2 of 2
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
GIP receptor agonism and the argument about direction
GIP receptor agonism and the argument about direction — setting out what I have, and where I think it stops being reliable. A question about GIP receptor agonism that I think has a definite answer, unlike…
|
2 | 867 | 10mo | |
|
Vagal afferents and the gut-brain pathway — one year on
Vagal afferents and the gut-brain pathway — one year on Writing it up because I had to work it out twice and would rather nobody else did. An honest uncertainty about Vagal afferents rather than a disguised…
|
2 | 136 | 11mo | |
|
Second pass at: Isotonicity and what happens when you get it wrong
Second pass at: Isotonicity and what happens when you get it wrong — setting out what I have, and where I think it stops being reliable. Something about Isotonicity does not reconcile and I would like a…
|
+1 | 5 | 2.6k | 11mo |
|
Subcutaneous absorption kinetics and site differences
Posting this under the heading it deserves: Subcutaneous absorption kinetics and site differences Everything below is what sits behind that. Asking about subcutaneous absorption kinetics and site directly,…
|
+15 | 19 | 3.9k | 12mo |
|
Vagal afferents and the gut-brain pathway
On the subject in the title: Vagal afferents and the gut-brain pathway Working notes rather than a conclusion. Vagal afferents — I have the observation and I do not trust my interpretation of it, so I am…
|
+5 | 9 | 44k | 13mo |
|
[2026 update] Clearance pathways and what renal impairment changes
On the subject in the title: Clearance pathways and what renal impairment changes Working notes rather than a conclusion. What changes if the standard account of Clearance pathways is wrong? I ask because I…
|
+63 | 69 | 50k | 13mo |
|
Half-life, steady state, and accumulation worked through
Half-life, steady state, and accumulation worked through Writing it up because I had to work it out twice and would rather nobody else did. Working through the kinetics rather than the pharmacology, because I…
|
+115 | 130 | 44k | 13mo |
|
Albumin binding and how it produces a long half-life
Albumin binding and how it produces a long half-life — setting out what I have, and where I think it stops being reliable. A narrow question about albumin binding, deliberately narrow, because the broad…
|
+38 | 44 | 6.6k | 14mo |
|
Excipient function in a licensed injectable
Excipient function in a licensed injectable Writing it up because I had to work it out twice and would rather nobody else did. I was wrong about excipient function in a thread last spring and I would like to…
|
+3 | 7 | 36k | 14mo |
|
Excipient function in a licensed injectable — the long version
Posting this under the heading it deserves: Excipient function in a licensed injectable — the long version Everything below is what sits behind that. A narrow question about Excipient function, deliberately…
|
2 | 100 | 15mo | |
|
Why appetite effects are mostly central
Why appetite effects are mostly central I have a specific reason for asking rather than idle curiosity, and the context is below. Appetite effects: what I expected, what I found, and the gap between them. I…
|
2 | 56k | 16mo | |
|
Preservatives: function, testing, and limits
Preservatives: function, testing, and limits — setting out what I have, and where I think it stops being reliable. An honest uncertainty about preservatives rather than a disguised assertion. I do not know…
|
+23 | 27 | 3.7k | 16mo |
|
Biased agonism: a real phenomenon, an over-used explanation
Posting this under the heading it deserves: Biased agonism: a real phenomenon, an over-used explanation Everything below is what sits behind that. Trying to work out what would count as evidence on biased…
|
+130 | 135 | 23k | 16mo |
|
Second pass at: Albumin binding and how it produces a long half-life
Posting this under the heading it deserves: Second pass at: Albumin binding and how it produces a long half-life Everything below is what sits behind that. A narrow question about Albumin binding,…
|
+7 | 11 | 31k | 17mo |
|
Biased agonism: a real phenomenon, an over-used explanation — what changed since
Biased agonism: a real phenomenon, an over-used explanation — what changed since — setting out what I have, and where I think it stops being reliable. What changes if the standard account of Biased agonism is…
|
+49 | 56 | 47k | 17mo |
|
Coming back to: Adsorption to container surfaces and to plastics
Adsorption to container surfaces and to plastics — setting out what I have, and where I think it stops being reliable. Adsorption — I have the observation and I do not trust my interpretation of it, so I am…
|
2 | 459 | 17mo | |
|
Isotonicity and what happens when you get it wrong
On the subject in the title: Isotonicity and what happens when you get it wrong Working notes rather than a conclusion. I was wrong about isotonicity in a thread last spring and I would like to correct it…
|
+27 | 31 | 11k | 18mo |
|
Time to steady state after a dose increase
On the subject in the title: Time to steady state after a dose increase Working notes rather than a conclusion. Working through the kinetics rather than the pharmacology, because I think the confusion here is…
|
+151 | 163 | 9.7k | 21mo |
|
Buffers, pH and why a formulation is a formulation
Buffers, pH and why a formulation is a formulation Writing it up because I had to work it out twice and would rather nobody else did. A formulation question rather than a pharmacological one, though the two…
|
+11 | 15 | 51k | 21mo |
|
Second pass at: Buffers, pH and why a formulation is a formulation
Second pass at: Buffers, pH and why a formulation is a formulation Writing it up because I had to work it out twice and would rather nobody else did. Posting a small dataset on Buffers. It is mine, it is…
|
+24 | 28 | 1.5k | 21mo |